2014
DOI: 10.5966/sctm.2014-0221
|View full text |Cite
|
Sign up to set email alerts
|

Proceedings: Debilitating Eye Diseases

Abstract: SUMMARYDebilitating eye diseases such as age-related macular degeneration and retinitis pigmentosa currently represent a large unmet medical need that could potentially be addressed by stem cell therapy. A number of novel stem cell-based cellular therapies are now under development to treat a variety of eye diseases. The approaches being taken by the California Institute for Regenerative Medicine, together with its grantees, are discussed. STEM CELLS

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0
1

Year Published

2015
2015
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 7 publications
0
4
0
1
Order By: Relevance
“…He reported his five-year history of increasing frequency of visual hallucinations and was able to give a detailed and coherent description of his hallucinatory experiences. The patient suffered from retinitis pigmentosa, a degenerative eye disease causing severe vision impairment due to progressive degeneration of the rod photoreceptors in the retina [11]. At the age of 3 years, he began experiencing progressive and gradual loss of vision.…”
Section: Methodsmentioning
confidence: 99%
“…He reported his five-year history of increasing frequency of visual hallucinations and was able to give a detailed and coherent description of his hallucinatory experiences. The patient suffered from retinitis pigmentosa, a degenerative eye disease causing severe vision impairment due to progressive degeneration of the rod photoreceptors in the retina [11]. At the age of 3 years, he began experiencing progressive and gradual loss of vision.…”
Section: Methodsmentioning
confidence: 99%
“…Novel approaches may be of special importance for retinal degenerations, such as retinitis pigmentosa and age-related macular degenerations (Caras et al, 2014;Zarbin, 2016), which represent a significant cause of blindness and presently lack proven effective therapeutic options (Zarbin et al, 2014).…”
Section: D-tissue Generation In Microgravity: Impact On Outer Space mentioning
confidence: 99%
“…A human phase I/II clinical trial will evaluate the safety and tolerability of this tissueengineering product (TEP) in patients with gyrate atrophy. 101,109 The proof of concept with this TEP has been reported in RCS rats and in Yucatan pigs. 101,110 As human iPSCs can be obtained directly from the patient, they have the advantage of being autologous and therefore less immunogenic than ESCs for future cell transplantation studies.…”
Section: Cell Transplantation Using Human Pscsmentioning
confidence: 84%